StageZero Life Sciences Ltd. (SZLSF)
OTCMKTS · Delayed Price · Currency is USD
0.0005
0.00 (0.00%)
Feb 10, 2026, 9:30 AM EST
StageZero Life Sciences Revenue
StageZero Life Sciences had revenue of $499.66K in the quarter ending September 30, 2024, a decrease of -37.02%. This brings the company's revenue in the last twelve months to $2.88M, down -37.63% year-over-year. In the year 2022, StageZero Life Sciences had annual revenue of $3.80M, down -25.12%.
Revenue (ttm)
2.88M
Revenue Growth
-37.63%
P/S Ratio
1.26
Revenue / Employee
72.06K
Employees
40
Market Cap
3.64M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | 3.80M | -1.27M | -25.12% |
| Dec 31, 2021 | 5.07M | 916.35K | 22.07% |
| Dec 31, 2020 | 4.15M | 4.01M | 2,893.29% |
| Dec 31, 2019 | 138.70K | -47.17K | -25.38% |
| Dec 31, 2018 | 185.87K | -225.80K | -54.85% |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Centogene | 53.65M |
| Bioqual | 46.54M |
| Psychemedics | 19.69M |
| Aspira Women's Health | 9.34M |
| ProPhase Labs | 5.06M |
| Longduoduo Company | 4.15M |
| IDenta | 1.24M |
| InVitro International | 811.29K |
StageZero Life Sciences News
- 6 months ago - StageZero Announces Listing on the NEX Exchange - TheNewswire
- 9 months ago - StageZero Life Sciences and ElevationMD Introduce Aristotle and AVRT for the Early Detection of Cancer - TheNewswire
- 1 year ago - StageZero Life Sciences Announces Update on Filing of Full Year 2023 Financials Under the Failure To File Cease Trade Order - Accesswire
- 1 year ago - StageZero Life Sciences Announces Update on Filing of Full Year 2023 Financials under the Failure to File Cease Trade Order - Accesswire
- 1 year ago - StageZero Life Sciences Ltd. (SZLSF) Q1 2024 Earnings Call Transcript - Seeking Alpha
- 1 year ago - StageZero Life Sciences, Ltd Announces Q1 2024 Financial Results and Operational Update - Accesswire
- 2 years ago - StageZero Life Sciences Provides an Update on Application for Management Cease Trade Order - Accesswire
- 2 years ago - StageZero Life Sciences Announces Delay to Fourth Quarter and Year End 2023 Financial Results - Accesswire